Management of Chronic Antithrombotic Medication in Total Joint Arthroplasty: A Primer for the Orthopaedic Surgeon
The Journal of Arthroplasty · 2026-05 · 41 (5) · 1509-1517
DOI: 10.1016/j.arth.2025.09.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Arthroplasty, 2026-05. Verfasst von Theodor Di Pauli von Treuheim und 4 weiteren Autor:innen. Beteiligte Einrichtung: NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York. Hauptthemen laut MEDLINE: Fibrinolytic Agents, Arthroplasty, Replacement. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The increasing prevalence of chronic antithrombotic medication use among aging and medically complex total joint arthroplasty (TJA) patients poses major challenges, requiring a careful balance of thrombotic and bleeding risks. METHODS: This review aimed to summarize existing guidelines and supporting literature surrounding the perioperative management of chronic antithrombotics in patients undergoing TJA and identify remaining gaps and challenges to guide future research efforts. RESULTS: Current guidelines strongly recommend continuing aspirin throughout the perioperative period for TJA patients while advising the cessation of P2Y12 inhibitors and anticoagulants preoperatively, with specific timing dependent on patient- and procedure-related risks. There remains a critical gap in high-quality evidence and standardized guidelines regarding optimal postoperative resumption of chronic antithrombotics, leading to wide variability in practices and reliance on surgeon judgment. CONCLUSIONS: Future research efforts should prioritize developing evidence-based perioperative protocols tailored specifically for TJA patients on chronic antithrombotic therapy, similar to existing multidisciplinary guidelines for immunosuppressive management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York.
- California Northstate University College of Medicine, Elk Grove, California.
Zitieren
APA
Di Pauli von Treuheim, T., Ruff, G. L., Shanaa, J., Schwarzkopf, R., & Aggarwal, V. K. (2026). Management of Chronic Antithrombotic Medication in Total Joint Arthroplasty: A Primer for the Orthopaedic Surgeon. The Journal of Arthroplasty, 41(5), 1509-1517. https://doi.org/10.1016/j.arth.2025.09.020
Vancouver
Di Pauli von Treuheim T, Ruff GL, Shanaa J, Schwarzkopf R, Aggarwal VK. Management of Chronic Antithrombotic Medication in Total Joint Arthroplasty: A Primer for the Orthopaedic Surgeon. The Journal of Arthroplasty. 2026;41(5):1509-1517. doi:10.1016/j.arth.2025.09.020
BibTeX
@article{DiPaulivonTreuheim2026,
author = {Di Pauli von Treuheim, Theodor and Ruff, Garrett L and Shanaa, Jean and Schwarzkopf, Ran and Aggarwal, Vinay K},
title = {Management of Chronic Antithrombotic Medication in Total Joint Arthroplasty: A Primer for the Orthopaedic Surgeon},
journal = {The Journal of Arthroplasty},
year = {2026},
volume = {41},
number = {5},
pages = {1509--1517},
doi = {10.1016/j.arth.2025.09.020}
}
EUVIMED